Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Market cap
$1.4B
91M shares
52-week range
$13.00 – $18.16
36% from low
Exchange
NASDAQ
CS
Borrow rate
0.70%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $333.9M | $750.6M | $1.20B | $1.72B | $2.33B | $2.88B | $3.30B | $3.62B |
| Cost of revenue | $168.1M | $308.9M | $434.7M | $652.3M | $859.6M | $1.11B | $1.22B | $1.29B |
| Gross profit | $165.9M | $441.8M | $766.5M | $1.07B | $1.47B | $1.77B | $2.09B | $2.34B |
| Gross margin | 49.7% | 58.9% | 63.8% | 62.1% | 63.1% | 61.4% | 63.2% | 64.5% |
| R&D | $0 | $0 | $32.0K | $0 | $9.4M | $21.5M | $20.1M | $0 |
| Operating income | $96.4M | $205.3M | $363.3M | $440.9M | $664.1M | $767.1M | $1.01B | $1.19B |
| EBITDA | $104.3M | $315.6M | $472.8M | $603.3M | $929.0M | $1.11B | $1.22B | $1.34B |
| Net income | $86.4M | $153.9M | $292.1M | $223.3M | $373.6M | $386.3M | $631.5M | $737.7M |
| Net margin | 25.9% | 20.5% | 24.3% | 13.0% | 16.0% | 13.4% | 19.1% | 20.4% |
| EPS (diluted) | 0.98 | 2.02 | 3.12 | 2.37 | 4.15 | 4.27 | 6.93 | 8.11 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $4.0B | $8.95 | $8.58–$9.28 | 3 |
| 2027 | $4.3B | $10.12 | $9.70–$10.54 | 4 |
| 2028 | $4.6B | $10.90 | $9.02–$11.85 | 3 |
Forward consensus · source: Financial Modeling Prep
Afya Ltd is a medical education group based in Brazil. Its education portfolio has several courses in addition to Medicine, such as Management, Dentistry, Law, Engineering, Nursing, Psychology, and Accounting Sciences, among others. It has three segments; Undergraduate, deriving key revenue provides educational services through undergraduate courses related to medical school, undergraduate health science and other ex-health undergraduate programs, Continuing Education provides medical education, specialization and graduate courses in medicine, delivered through digital and in-person content; and Medical practice solution provides clinical decision, clinical management and doctor-patient relationships for physicians and provide access, demand and efficiency for the healthcare players.
www.afya.com.brNo one on the platform currently holds AFYA.
No tracked institution reports a position in AFYA as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-03-25 | $0.6565 | 2026-04-06 |
| 2025-03-26 | $0.2320 | 2025-04-04 |
No one on the platform has traded AFYA yet.
| — |
| IMKTAIngles Markets, Incorporated | $88.37 | -1.14% | $1.7B | — |
| PXEDPhoenix Education Partners, Inc | $32.94 | -0.51% | $1.2B | — |
Source: Financial Modeling Prep · peers by sector/industry
Trading at 2.0× earnings vs its 3.2× historical median P/E.
Fair value ≈ $23.74 · price $14.87 today
Fair-value line = the stock's median historical P/E × earnings. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
$AFYA is holding at 14.93. Sentiment is currently weighed down by reports of poor school performance and reduced access to public financing, compounded by recent insider divestment.
View on StockTwits ↗$AFYA)is holding at 14.93. Sentiment is currently weighed down by reports of poor school performance and reduced access to public financing, compounded by recent insider divestment.
View on StockTwits ↗$AFYA Share Price: $14.70 Contract Selected: Dec 18, 2026 $15 Calls Buy Zone: $1.10 – $1.37 Target Zone: $1.82 – $2.22 Potential Upside: 55% ROI Time to Expiration: 190 Days | Updates via https://fxcapta.com/stockinfo/
View on StockTwits ↗Wall St is expecting 0.42 EPS for $AFYA Q2 [Reporting 08/26 AMC] http://www.estimize.com/intro/afya?chart=historical&metric_name=eps&utm_co
View on StockTwits ↗Wall St is expecting 0.58 EPS for $AFYA Q1 [Reporting 05/27 AMC] http://www.estimize.com/intro/afya?chart=historical&metric_name=eps&utm_co
View on StockTwits ↗$AFYA Q1 '26 Earnings Results & Recap • Reported GAAP EPS of $2.88 up 3.23% YoY • Reported revenue of $1.01B up 8.15% YoY • Afya reaffirms its 2026 guidance, expecting revenue between R$3.95B and R$4.1B, Adjusted EBITDA from R$1.7B to R$1.8B, and CAPEX from R$340M to R$380M.
View on StockTwits ↗$AFYA I remember buying thinking 100$ next year 5 years ago 😢
View on StockTwits ↗Insider Selling Red Flags: What’s Going On? A few big names had insider selling last week, and it’s worth taking note: 6 directors at LANDS' END, INC. ($LE) sold $416.83K 3 insiders at JABIL INC ($JBL) (CEO, EVP, SVP) sold a whopping $5.03M 3 insiders at Afya Ltd ($AFYA) (CEO, VP Legal) cashed out $799.68K 2 insiders at TD SYNNEX CORP ($SNX) (CFO, President of Europe) sold $1.22M Insider selling is always a watch-out for potential weakness. Are these leaders losing confidence? Or is it just routine? Either way, something to monitor closely – insider moves can be a key signal for traders. Stay sharp!
View on StockTwits ↗Wall St is expecting 0.54 EPS for $AFYA Q1 [Reporting 05/27 AMC] http://www.estimize.com/intro/afya?chart=historical&metric_name=eps&utm_co
View on StockTwits ↗$AFYA Share Price: $14.88 Contract Selected: Sep 18, 2026 $20 Calls Buy Zone: $0.30 – $0.37 Target Zone: $0.56 – $0.68 Potential Upside: 77% ROI Time to Expiration: 170 Days | Updates via https://fxcapta.com/stockinfo/
View on StockTwits ↗Wall St is expecting 0.35 EPS for $AFYA Q4 [Reporting 03/27 AMC] http://www.estimize.com/intro/afya?chart=historical&metric_name=eps&utm_co
View on StockTwits ↗$AFYA Q4 '25 Earnings Results & Recap • Reported GAAP EPS of $1.91 up 15.06% YoY • Reported revenue of $912.99M up 7.54% YoY • Afya expects FY2026 Revenue to range from R$3.95B to R$4.1B and Adjusted EBITDA between R$1.7B and R$1.8B, excluding future acquisitions. CAPEX is guided between R$340M and R$380M.
View on StockTwits ↗$AFYA Q4 '25 Earnings Results & Recap • Reported GAAP EPS of $1.91 up 15.06% YoY • Reported revenue of $912.99M up 7.54% YoY • Afya expects FY2026 Revenue to range between R$3.95B and R$4.1B, and Adjusted EBITDA to be between R$1.7B and R$1.8B, excluding any acquisitions.
View on StockTwits ↗Wall St is expecting 0.35 EPS for $AFYA Q4 [Reporting 03/27 AMC] http://www.estimize.com/intro/afya?chart=historical&metric_name=eps&utm_co
View on StockTwits ↗$AFYA Current Stock Price: $13.42 Contracts to trade: $12.5 AFYA Mar 20 2026 Call Entry: $3.30 Exit: $4.29 ROI: 30% Hold ~23 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.